601 related articles for article (PubMed ID: 37482657)
1. Colorectal cancer and gut microbiota studies in China.
Wang Z; Dan W; Zhang N; Fang J; Yang Y
Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
[TBL] [Abstract][Full Text] [Related]
2. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
4. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
5. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.
Shen S; Huo D; Ma C; Jiang S; Zhang J
Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421
[TBL] [Abstract][Full Text] [Related]
7. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
Fan X; Jin Y; Chen G; Ma X; Zhang L
Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
Wong SH; Yu J
Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
[TBL] [Abstract][Full Text] [Related]
10. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
11. Roles of Gut Microbiota in Colorectal Carcinogenesis Providing a Perspective for Early Diagnosis and Treatment.
Nouri R; Hasani A; Asgharzadeh M; Sefidan FY; Hemmati F; Rezaee MA
Curr Pharm Biotechnol; 2022; 23(13):1569-1580. PubMed ID: 35255786
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer: the facts in the case of the microbiota.
Clay SL; Fonseca-Pereira D; Garrett WS
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235
[TBL] [Abstract][Full Text] [Related]
14. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
15. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers.
Dai Z; Coker OO; Nakatsu G; Wu WKK; Zhao L; Chen Z; Chan FKL; Kristiansen K; Sung JJY; Wong SH; Yu J
Microbiome; 2018 Apr; 6(1):70. PubMed ID: 29642940
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
Liu Y; Lau HC; Cheng WY; Yu J
Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
[TBL] [Abstract][Full Text] [Related]
17. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
18. Microbe-based management for colorectal cancer.
Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota in colorectal cancer development and therapy.
Wong CC; Yu J
Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]